A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder

Conditions:		Major Depressive Disorder
Purpose:		The purpose of this study is to evaluate the efficacy, safety, and tolerability of F2695 SR fixed doses versus placebo in the treatment of outpatients with major depressive disorder.
Study Summary:
Criteria:		Inclusion Criteria: - Men and women, 18-65 years old - Currently meet the DSM-IV-TR criteria for Major Depressive Disorder - The patient's current depressive episode must be at least 8 weeks in duration Exclusion Criteria: - Women who are pregnant, women who will be breastfeeding during the study, and women with childbearing potential who are not practicing a reliable method of birth control - Patients with a history of meeting DSM-IV-TR criteria for: - any manic or hypomanic episode - schizophrenia or any other psychotic disorder - obsessive-compulsive disorder - Patients who are considered a suicide risk
NCT ID:		NCT00969709
Primary Contact:		Study Director Carl Gommoll, MS Forest Research Institute, a subsidiary of Forest Laboratories Inc. Sandra Beaird, PhD Phone: 1-800-678-1605 ext. 66297 Email: info@forestpharm.com
Backup Contact:		N/A
Location Contact:		Seattle, Washington 98104 United States *There is no listed contact information for this specific location.* Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		June 18, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.